Soleno Therapeutics Inc
SLNODelisted May 18, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001484565
Soleno Therapeutics Inc was delisted on May 18, 2026; its insiders filed their last Form 4 on May 18, 2026; 227 institutions reported holding it in 13F filings for Q1 2026, worth $2.09B in total; no superinvestor held it.
Q4 2023 vs. Q3 2023
How the institutions holding Soleno Therapeutics Inc changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 54 | 76 | +22 |
| Shares | 20.3M | 31.4M | +11.1M (+54.7%) |
| Value | $598.8M | $1.26B | +$665.5M (+111.1%) |
New holders (34)
Institutions that held Soleno Therapeutics Inc at the end of Q4 2023 but not at the end of Q3 2023.
Sold out (12)
Institutions that held Soleno Therapeutics Inc at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Ra Capital Management, L.P. | 1,239,000 | $36.6M |
| Fairmount Funds Management LLC | 1,142,473 | $33.7M |
| Soleus Capital Management, L.P. | 325,000 | $9.59M |
| Logos Global Management LP | 125,000 | $3.69M |
| Parkman Healthcare Partners LLC | 100,000 | $2.95M |
| Renaissance Technologies LLC | 61,554 | $1.82M |
| Moore Capital Management, LP | 50,000 | $1.48M |
| Walleye Capital LLC | 46,244 | $1.36M |
| Citadel Advisors LLC | 40,625 | $1.20M |
| Maven Securities LTD | 25,000 | $737.8K |
| Sassicaia Capital Advisers LLC | 8,655 | $255.4K |
| Clayton Partners LLC | 7,000 | $206.6K |